
The final distribution to shareholders is expected on or about Sept. 1.
The final distribution to shareholders is expected on or about Sept. 1.
The Daily Hit is a recap of the top financial news stories for January 18, 2023.
New York’s First Cannabis Retailer Sued over Website Accessibility
The nonprofit Housing Works, which launched recreational cannabis sales in New York City last month, is now facing a legal fight over its website, in a suit filed by a blind woman, claiming it’s in violation of the Americans with Disabilities Act. Read more here.
Bespoke Financial Sues ‘In Da Cut’ For Not Paying Its Debt
Cannabis lender Bespoke Financial is suing California-based In Da Cut LLC’s CEO, Drayten Howell, and DOES 1-10 for not paying back the money that was borrowed. According to the court complaint filed on Jan. 11, Bespoke loaned money to In Da Cut in February 2022 so that In Da Cut could pay third-party vendors for goods and services that had been purchased. Read more here.
Michigan Cannabis Sales Hit New Record
Michigan had a banner year in 2022, ending with $221.7 million in sales for the month of December alone and a full-year total of $2.3 billion, a new record for the state’s marijuana industry. That annual sales figure is a 28% increase from 2021. Read more here.
Cannabis ETF Investors: Bad Timers, but Committed
Cannabis ETF investors are a loyal bunch, but not so great at market timing. Just look at one of the more popular cannabis ETFs, the AdvisorShares Pure U.S. Cannabis ETF managed by Dan Ahrens, where investors seem to buy high and sell low. Read more here.
Body and Mind Inc.
Body and Mind Inc. (CSE: BAMM) (OTCQB: BMMJ), a multistate operations-focused cannabis company, posted revenue for fiscal year 2022, ended July 31, 2022, of $31.6 million, a 17.6% increase over FY 2021 revenue of $26.9 million. Read more here.
Nass Valley Gardens
Nass Valley Gardens Inc., a Nevada registered C-Corp and a wholly owned subsidiary of Nass Valley Gateway Ltd., (CSE: NVG) (OTC: NSVGF)(FSE: 3NVN), signed a definite agreement to purchase 100% of Super Scientific Laboratories LLC, a manufacturer of products focused on CBD, cannabidiols, vapes, gummies, soaps, lotions, and other consumer products. Read more here.
The SAFE Act bet didn't pan out for investors.
As the Presidential election nears, it seems the topic of cannabis legalization is driving investor interest in the industry. Cannabis ETF issuer ETFMG, who manages ETFMG Alternative Harvest ETF (NYSE Arca: MJ), reported its 1,000th creation unit sold on October 12, 2020. The company said that the subject of legalization of cannabis in several states has led to increased investor demand evidenced by the increased daily trading volume. Shortly after the Vice-Presidential debate, MJ saw trading volume increase three times its normal activity, 750,000 to nearly 2.4 million. MJ currently has 50 million shares outstanding. Since the beginning of Q4 2020, the Fund is up 10.66%.
The Democrat party platform of Vice President Joe Biden & Senator Kamala Harris, officially says they would seek to decriminalize marijuana use and reschedule it (from DEA Schedule I) through executive action on the federal level. They support the legalization of medical marijuana nationwide and believe states should be able to make their own decisions about recreational use. Their platform believes the Justice Department should not launch federal prosecutions of conduct that is legal at the state level, as well as that all past criminal convictions for cannabis use should be automatically expunged (this is a combination of previously proposed STATES ACT and MORE ACT).
On the Republican side, if President Trump were reelected, some say it would not be seen as negative for the cannabis industry. In the past four years under the Trump Administration, legal sales of cannabis in the U.S. have expanded more than at any other time in history. In addition, his administration has not interfered with state law cannabis legalization, which has increased tremendously. However, President Trump did ask some swing states to remove any cannabis legislation from the ballots because that would draw more Democrats to vote. Plus, despite many cannabis supporters who believe Trump is friendly to the industry, the Uniform Crime Report from the FBI reported that more people were arrested for cannabis in 2019 than for all violent crimes put together. The hard data from the FBI’s report clearly showed that police arrested 545,602 people for cannabis-related crimes in 2019. “That arrest rate is 9% higher than the 495,871 people arrested for violent crimes the same year.”
Looking back in history, Democratic President Franklin D. Roosevelt’s 1932 presidential campaign included the repeal of Prohibition. Following his win, Congress proposed the 21st Amendment to end Prohibition.
“Regardless of who wins the White House, U.S. cannabis expansion is expected to continue past November,” said Dan Ahrens, chief operating officer, and portfolio manager at AdvisorShares. Ahrens serves as the portfolio manager of the AdvisorShares Pure Cannabis ETF (Ticker: YOLO), AdvisorShares Pure US Cannabis ETF (Ticker: MSOS) and the AdvisorShares Vice ETF (Ticker: ACT). He added that Arizona and New Jersey each have ballot proposals for voters to decide on legalizing recreational cannabis use. Both states currently have successful medical marijuana programs too. “Other states including South Dakota, Montana and Mississippi also have recreational and/or medical marijuana proposals up for vote. Pending New Jersey’s ballot vote, it is widely thought that Pennsylvania and New York could soon approve recreational marijuana use by legislative action, rather than ballot measure, which was how Illinois approved recreational use last year. At the very least, given the populations of Arizona and New Jersey, recreational cannabis legalization would be a huge victory for U.S. cannabis companies.”
AdvisorShares has launched the AdvisorShares Pure US Cannabis ETF (Ticker: MSOS), which will begin trading this Wednesday (September 2nd). MSOS becomes the first U.S.-listed active ETF to deliver exposure dedicated solely to American cannabis companies, including multi-state operators (MSOs). MSOs are U.S. companies directly involved in the legal production and distribution of cannabis in states where approved.
The company said that MSOS will seek long-term capital appreciation by investing entirely in legal, domestic cannabis equity securities. MSOS’ domestic equity strategy allows this active ETF to allocate its underlying portfolio among multi-state operator (MSO) companies as well as other U.S.-based cannabis-focused areas such a REITs, cannabidiol (CBD), pharmaceutical and hydroponics.
MSOS becomes AdvisorShare’s second dedicated cannabis investment strategy alongside the AdvisorShares Pure Cannabis ETF (Ticker: YOLO). When YOLO launched on April 18, 2019, it became the first U.S.-listed active ETF dedicated to cannabis exposure – investing in both domestic and foreign cannabis equity securities. MSOS joins YOLO as the only U.S.-listed cannabis ETFs that maintain an established, Federal bank as fund custodian.
The portfolio manager of MSOS is Dan Ahrens, AdvisorShares chief operating officer, who also serves as portfolio manager of YOLO and the AdvisorShares Vice ETF (Ticker: ACT). Ahrens carries a well-established expertise of investing in cannabis and other highly regulated areas of the market.
“We are pleased to offer MSOS in addition to YOLO which we believe responds further to meeting investors’ demands for more U.S. cannabis investment exposure,” said Ahrens. “We believe that the U.S. clearly represents the most attractive opportunity for cannabis investment and remains an exponentially larger market than the Canadian cannabis market. We feel strongly that our active portfolio management serves as the most advantageous way to invest in the emerging cannabis space.”
Ahrens has long held the view that the U.S. cannabis market is largely untapped and possesses the most significant upside potential in the global cannabis marketplace. Early in the COVID-19 crisis, cannabis dispensaries were deemed essential business in most U.S. states and never closed. Both CBD and marijuana have sold at record levels throughout Canada and legal states in the U.S. this year. Ahrens steadfastly believes security selection and risk management remains imperative in this emerging and volatile space.
Unpack the industry with the daily cannabis newsletter for business leaders.
Unpack the industry with the daily cannabis newsletter for business leaders.